Will Robinhood Win AI Investing?
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
Sell
21
OSUR Quote, Financials, Valuation and Earnings
Last price:
$2.50
Seasonality move
:
-0.34%
Day range:
$2.44 - $2.60
52-week range:
$2.08 - $4.22
Dividend yield:
0%
P/E ratio:
26.67x
P/S ratio:
1.47x
P/B ratio:
0.49x
Volume:
498.8K
Avg. volume:
733.6K
1-year change:
-35.16%
Market cap:
$178.6M
Revenue:
$185.8M
EPS (TTM):
-$0.81
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
OSUR
OraSure Technologies, Inc.
|
$29.1M | -$0.15 | -29.38% | -5.2% | $4.50 |
|
CATX
Perspective Therapeutics, Inc.
|
$206.8K | -$0.32 | -9.65% | -37.91% | $12.3077 |
|
PMI
Picard Medical
|
-- | -- | -- | -- | -- |
|
VNRX
VolitionRX Ltd.
|
$715.6K | -$0.05 | 272.5% | -33.67% | $2.60 |
|
VTAK
Catheter Precision, Inc.
|
$310K | -$0.20 | 118.75% | -11.57% | -- |
|
XTNT
Xtant Medical Holdings, Inc.
|
$32.7M | -- | 2.34% | -100% | $1.50 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
OSUR
OraSure Technologies, Inc.
|
$2.49 | $4.50 | $178.6M | 26.67x | $0.00 | 0% | 1.47x |
|
CATX
Perspective Therapeutics, Inc.
|
$2.4000 | $12.3077 | $178.4M | -- | $0.00 | 0% | 162.73x |
|
PMI
Picard Medical
|
-- | -- | -- | -- | $0.00 | 0% | -- |
|
VNRX
VolitionRX Ltd.
|
$0.30 | $2.60 | $36.8M | -- | $0.00 | 0% | 20.54x |
|
VTAK
Catheter Precision, Inc.
|
$2.38 | -- | $2.9M | 0.40x | $0.00 | 0% | 11.19x |
|
XTNT
Xtant Medical Holdings, Inc.
|
$0.62 | $1.50 | $86.2M | 60.39x | $0.00 | 0% | 0.67x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
OSUR
OraSure Technologies, Inc.
|
3.59% | 0.885 | 5.8% | 5.99x |
|
CATX
Perspective Therapeutics, Inc.
|
1.35% | 3.691 | 1.3% | 8.47x |
|
PMI
Picard Medical
|
-- | 0.000 | -- | -- |
|
VNRX
VolitionRX Ltd.
|
-48.16% | 2.566 | 15.4% | 0.04x |
|
VTAK
Catheter Precision, Inc.
|
68.63% | -0.348 | 537.37% | 0.41x |
|
XTNT
Xtant Medical Holdings, Inc.
|
39.2% | 2.955 | 35.76% | 1.08x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
OSUR
OraSure Technologies, Inc.
|
$10.4M | -$15.7M | -14.75% | -15.25% | -56.71% | -$11M |
|
CATX
Perspective Therapeutics, Inc.
|
-$566K | -$27.9M | -37.13% | -37.63% | -13330.62% | -$18.3M |
|
PMI
Picard Medical
|
-- | -- | -- | -- | -- | -- |
|
VNRX
VolitionRX Ltd.
|
$318.2K | -$5.1M | -- | -- | -813.17% | -$3.5M |
|
VTAK
Catheter Precision, Inc.
|
-$320K | -$3M | -79.27% | -192.05% | -1336.73% | -$2.2M |
|
XTNT
Xtant Medical Holdings, Inc.
|
$22M | $2.5M | 2.15% | 3.78% | 7.64% | $4.2M |
OraSure Technologies, Inc. vs. Competitors
-
Which has Higher Returns OSUR or CATX?
Perspective Therapeutics, Inc. has a net margin of -50.63% compared to OraSure Technologies, Inc.'s net margin of -12425.36%. OraSure Technologies, Inc.'s return on equity of -15.25% beat Perspective Therapeutics, Inc.'s return on equity of -37.63%.
Company Gross Margin Earnings Per Share Invested Capital OSUROraSure Technologies, Inc.38.32% -$0.19 $375.4M CATXPerspective Therapeutics, Inc.-270.81% -$0.35 $245.5M -
What do Analysts Say About OSUR or CATX?
OraSure Technologies, Inc. has a consensus price target of $4.50, signalling upside risk potential of 80.72%. On the other hand Perspective Therapeutics, Inc. has an analysts' consensus of $12.3077 which suggests that it could grow by 412.82%. Given that Perspective Therapeutics, Inc. has higher upside potential than OraSure Technologies, Inc., analysts believe Perspective Therapeutics, Inc. is more attractive than OraSure Technologies, Inc..
Company Buy Ratings Hold Ratings Sell Ratings OSUROraSure Technologies, Inc.1 2 0 CATXPerspective Therapeutics, Inc.12 1 0 -
Is OSUR or CATX More Risky?
OraSure Technologies, Inc. has a beta of 0.747, which suggesting that the stock is 25.31% less volatile than S&P 500. In comparison Perspective Therapeutics, Inc. has a beta of 1.222, suggesting its more volatile than the S&P 500 by 22.249%.
-
Which is a Better Dividend Stock OSUR or CATX?
OraSure Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Perspective Therapeutics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. OraSure Technologies, Inc. pays -- of its earnings as a dividend. Perspective Therapeutics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios OSUR or CATX?
OraSure Technologies, Inc. quarterly revenues are $27.1M, which are larger than Perspective Therapeutics, Inc. quarterly revenues of $209K. OraSure Technologies, Inc.'s net income of -$13.7M is higher than Perspective Therapeutics, Inc.'s net income of -$26M. Notably, OraSure Technologies, Inc.'s price-to-earnings ratio is 26.67x while Perspective Therapeutics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for OraSure Technologies, Inc. is 1.47x versus 162.73x for Perspective Therapeutics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income OSUROraSure Technologies, Inc.1.47x 26.67x $27.1M -$13.7M CATXPerspective Therapeutics, Inc.162.73x -- $209K -$26M
-
Which has Higher Returns OSUR or PMI?
Picard Medical has a net margin of -50.63% compared to OraSure Technologies, Inc.'s net margin of --. OraSure Technologies, Inc.'s return on equity of -15.25% beat Picard Medical's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital OSUROraSure Technologies, Inc.38.32% -$0.19 $375.4M PMIPicard Medical-- -- -- -
What do Analysts Say About OSUR or PMI?
OraSure Technologies, Inc. has a consensus price target of $4.50, signalling upside risk potential of 80.72%. On the other hand Picard Medical has an analysts' consensus of -- which suggests that it could fall by --. Given that OraSure Technologies, Inc. has higher upside potential than Picard Medical, analysts believe OraSure Technologies, Inc. is more attractive than Picard Medical.
Company Buy Ratings Hold Ratings Sell Ratings OSUROraSure Technologies, Inc.1 2 0 PMIPicard Medical0 0 0 -
Is OSUR or PMI More Risky?
OraSure Technologies, Inc. has a beta of 0.747, which suggesting that the stock is 25.31% less volatile than S&P 500. In comparison Picard Medical has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock OSUR or PMI?
OraSure Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Picard Medical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. OraSure Technologies, Inc. pays -- of its earnings as a dividend. Picard Medical pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios OSUR or PMI?
OraSure Technologies, Inc. quarterly revenues are $27.1M, which are larger than Picard Medical quarterly revenues of --. OraSure Technologies, Inc.'s net income of -$13.7M is higher than Picard Medical's net income of --. Notably, OraSure Technologies, Inc.'s price-to-earnings ratio is 26.67x while Picard Medical's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for OraSure Technologies, Inc. is 1.47x versus -- for Picard Medical. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income OSUROraSure Technologies, Inc.1.47x 26.67x $27.1M -$13.7M PMIPicard Medical-- -- -- --
-
Which has Higher Returns OSUR or VNRX?
VolitionRX Ltd. has a net margin of -50.63% compared to OraSure Technologies, Inc.'s net margin of -862.39%. OraSure Technologies, Inc.'s return on equity of -15.25% beat VolitionRX Ltd.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital OSUROraSure Technologies, Inc.38.32% -$0.19 $375.4M VNRXVolitionRX Ltd.50.73% -$0.05 -$24.7M -
What do Analysts Say About OSUR or VNRX?
OraSure Technologies, Inc. has a consensus price target of $4.50, signalling upside risk potential of 80.72%. On the other hand VolitionRX Ltd. has an analysts' consensus of $2.60 which suggests that it could grow by 767.53%. Given that VolitionRX Ltd. has higher upside potential than OraSure Technologies, Inc., analysts believe VolitionRX Ltd. is more attractive than OraSure Technologies, Inc..
Company Buy Ratings Hold Ratings Sell Ratings OSUROraSure Technologies, Inc.1 2 0 VNRXVolitionRX Ltd.4 2 0 -
Is OSUR or VNRX More Risky?
OraSure Technologies, Inc. has a beta of 0.747, which suggesting that the stock is 25.31% less volatile than S&P 500. In comparison VolitionRX Ltd. has a beta of 1.258, suggesting its more volatile than the S&P 500 by 25.804%.
-
Which is a Better Dividend Stock OSUR or VNRX?
OraSure Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. VolitionRX Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. OraSure Technologies, Inc. pays -- of its earnings as a dividend. VolitionRX Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios OSUR or VNRX?
OraSure Technologies, Inc. quarterly revenues are $27.1M, which are larger than VolitionRX Ltd. quarterly revenues of $627.3K. OraSure Technologies, Inc.'s net income of -$13.7M is lower than VolitionRX Ltd.'s net income of -$5.4M. Notably, OraSure Technologies, Inc.'s price-to-earnings ratio is 26.67x while VolitionRX Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for OraSure Technologies, Inc. is 1.47x versus 20.54x for VolitionRX Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income OSUROraSure Technologies, Inc.1.47x 26.67x $27.1M -$13.7M VNRXVolitionRX Ltd.20.54x -- $627.3K -$5.4M
-
Which has Higher Returns OSUR or VTAK?
Catheter Precision, Inc. has a net margin of -50.63% compared to OraSure Technologies, Inc.'s net margin of -1037.17%. OraSure Technologies, Inc.'s return on equity of -15.25% beat Catheter Precision, Inc.'s return on equity of -192.05%.
Company Gross Margin Earnings Per Share Invested Capital OSUROraSure Technologies, Inc.38.32% -$0.19 $375.4M VTAKCatheter Precision, Inc.-141.59% -$1.70 $21.3M -
What do Analysts Say About OSUR or VTAK?
OraSure Technologies, Inc. has a consensus price target of $4.50, signalling upside risk potential of 80.72%. On the other hand Catheter Precision, Inc. has an analysts' consensus of -- which suggests that it could grow by 1496.69%. Given that Catheter Precision, Inc. has higher upside potential than OraSure Technologies, Inc., analysts believe Catheter Precision, Inc. is more attractive than OraSure Technologies, Inc..
Company Buy Ratings Hold Ratings Sell Ratings OSUROraSure Technologies, Inc.1 2 0 VTAKCatheter Precision, Inc.0 0 0 -
Is OSUR or VTAK More Risky?
OraSure Technologies, Inc. has a beta of 0.747, which suggesting that the stock is 25.31% less volatile than S&P 500. In comparison Catheter Precision, Inc. has a beta of -1.301, suggesting its less volatile than the S&P 500 by 230.084%.
-
Which is a Better Dividend Stock OSUR or VTAK?
OraSure Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Catheter Precision, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. OraSure Technologies, Inc. pays -- of its earnings as a dividend. Catheter Precision, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios OSUR or VTAK?
OraSure Technologies, Inc. quarterly revenues are $27.1M, which are larger than Catheter Precision, Inc. quarterly revenues of $226K. OraSure Technologies, Inc.'s net income of -$13.7M is lower than Catheter Precision, Inc.'s net income of -$2.3M. Notably, OraSure Technologies, Inc.'s price-to-earnings ratio is 26.67x while Catheter Precision, Inc.'s PE ratio is 0.40x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for OraSure Technologies, Inc. is 1.47x versus 11.19x for Catheter Precision, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income OSUROraSure Technologies, Inc.1.47x 26.67x $27.1M -$13.7M VTAKCatheter Precision, Inc.11.19x 0.40x $226K -$2.3M
-
Which has Higher Returns OSUR or XTNT?
Xtant Medical Holdings, Inc. has a net margin of -50.63% compared to OraSure Technologies, Inc.'s net margin of 3.93%. OraSure Technologies, Inc.'s return on equity of -15.25% beat Xtant Medical Holdings, Inc.'s return on equity of 3.78%.
Company Gross Margin Earnings Per Share Invested Capital OSUROraSure Technologies, Inc.38.32% -$0.19 $375.4M XTNTXtant Medical Holdings, Inc.66.13% $0.01 $82.9M -
What do Analysts Say About OSUR or XTNT?
OraSure Technologies, Inc. has a consensus price target of $4.50, signalling upside risk potential of 80.72%. On the other hand Xtant Medical Holdings, Inc. has an analysts' consensus of $1.50 which suggests that it could grow by 143.51%. Given that Xtant Medical Holdings, Inc. has higher upside potential than OraSure Technologies, Inc., analysts believe Xtant Medical Holdings, Inc. is more attractive than OraSure Technologies, Inc..
Company Buy Ratings Hold Ratings Sell Ratings OSUROraSure Technologies, Inc.1 2 0 XTNTXtant Medical Holdings, Inc.2 0 0 -
Is OSUR or XTNT More Risky?
OraSure Technologies, Inc. has a beta of 0.747, which suggesting that the stock is 25.31% less volatile than S&P 500. In comparison Xtant Medical Holdings, Inc. has a beta of -0.052, suggesting its less volatile than the S&P 500 by 105.153%.
-
Which is a Better Dividend Stock OSUR or XTNT?
OraSure Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xtant Medical Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. OraSure Technologies, Inc. pays -- of its earnings as a dividend. Xtant Medical Holdings, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios OSUR or XTNT?
OraSure Technologies, Inc. quarterly revenues are $27.1M, which are smaller than Xtant Medical Holdings, Inc. quarterly revenues of $33.3M. OraSure Technologies, Inc.'s net income of -$13.7M is lower than Xtant Medical Holdings, Inc.'s net income of $1.3M. Notably, OraSure Technologies, Inc.'s price-to-earnings ratio is 26.67x while Xtant Medical Holdings, Inc.'s PE ratio is 60.39x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for OraSure Technologies, Inc. is 1.47x versus 0.67x for Xtant Medical Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income OSUROraSure Technologies, Inc.1.47x 26.67x $27.1M -$13.7M XTNTXtant Medical Holdings, Inc.0.67x 60.39x $33.3M $1.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
56
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
81
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Buy
56
SMX alert for Dec 6
SMX (Security Matters) Plc [SMX] is up 134.09% over the past day.
Buy
62
PRAX alert for Dec 6
Praxis Precision Medicines, Inc. [PRAX] is up 30.47% over the past day.
Sell
13
PSN alert for Dec 6
Parsons Corp. [PSN] is down 21.1% over the past day.
